Clintrax Global Expands Service Offerings To Include Global Investigator Payments
RALEIGH, N.C., March 20, 2014 /PRNewswire/ — Clintrax Global, Inc., a worldwide clinical trial contract negotiation company located in Raleigh, NC, recently announced the addition of global investigator payments to its list of client services. Investigator payments are an essential part of the clinical trial lifecycle in which the site and other responsible contracting parties are compensated for services rendered and work performed throughout the course of a particular study.
Clintrax’s expertise lies in negotiating clinical trial contracts and budgets on behalf of pharmaceutical companies and contract research organizations (CROs) worldwide, leading to a natural and streamlined progression into offering global payments for performance upon those contracts. Clintrax has combined local knowledge of each country’s customs, legal, and regulatory environments with innovative tracking technology and verification processes to create a dependable payments service for both current and prospective clients.
Clintrax Global’s CEO, Brandon Evans, thinks the company’s blend of experienced global payments oversight combined with leading-edge tracking technology will reduce errors often found in traditional clinical research payment practices. “We are able to leverage our depth of experience with clinical trial budgets and payment terms to tailor our payment processes to a country’s specific requirements. In-country knowledge is what sets us apart in all aspects of what we do.”
About Clintrax Global
Clintrax Global, Inc. is a Raleigh-based company specializing in global clinical trial contract negotiation and investigator payments. The company acts as a functional service provider for pharmaceutical/biotechnology companies and CROs during the process of drug development. Clintrax provides these clients with worldwide contract negotiation and payments services to clinical trial sites including small clinics, large hospitals, and multicenter academic institutions in over 60 countries.
SOURCE Clintrax Global